
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Concept of an Ideal Antibiotic: Implications for Drug Design
Márió Gajdács
Molecules (2019) Vol. 24, Iss. 5, pp. 892-892
Open Access | Times Cited: 250
Márió Gajdács
Molecules (2019) Vol. 24, Iss. 5, pp. 892-892
Open Access | Times Cited: 250
Showing 1-25 of 250 citing articles:
<p>Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA): One Health Perspective Approach to the Bacterium Epidemiology, Virulence Factors, Antibiotic-Resistance, and Zoonotic Impact</p>
Abdelazeem M. Algammal, Helal F. Hetta, Amr Elkelish, et al.
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 3255-3265
Open Access | Times Cited: 290
Abdelazeem M. Algammal, Helal F. Hetta, Amr Elkelish, et al.
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 3255-3265
Open Access | Times Cited: 290
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
Ghazala Muteeb, Md Tabish Rehman, Moyad Shahwan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1615-1615
Open Access | Times Cited: 284
Ghazala Muteeb, Md Tabish Rehman, Moyad Shahwan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1615-1615
Open Access | Times Cited: 284
The Continuing Threat of Methicillin-Resistant Staphylococcus aureus
Márió Gajdács
Antibiotics (2019) Vol. 8, Iss. 2, pp. 52-52
Open Access | Times Cited: 256
Márió Gajdács
Antibiotics (2019) Vol. 8, Iss. 2, pp. 52-52
Open Access | Times Cited: 256
The Demand for New Antibiotics: Antimicrobial Peptides, Nanoparticles, and Combinatorial Therapies as Future Strategies in Antibacterial Agent Design
Ángel León-Buitimea, Cesar R. Garza-Cárdenas, Javier A. Garza-Cervantes, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 233
Ángel León-Buitimea, Cesar R. Garza-Cárdenas, Javier A. Garza-Cervantes, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 233
<p>In-vitro blood-brain barrier models for drug screening and permeation studies: an overview</p>
Sounak Bagchi, Tanya Chhibber, Behnaz Lahooti, et al.
Drug Design Development and Therapy (2019) Vol. Volume 13, pp. 3591-3605
Open Access | Times Cited: 189
Sounak Bagchi, Tanya Chhibber, Behnaz Lahooti, et al.
Drug Design Development and Therapy (2019) Vol. Volume 13, pp. 3591-3605
Open Access | Times Cited: 189
It’s Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa
Payam Behzadi, Zoltan Baráth, Márió Gajdács
Antibiotics (2021) Vol. 10, Iss. 1, pp. 42-42
Open Access | Times Cited: 183
Payam Behzadi, Zoltan Baráth, Márió Gajdács
Antibiotics (2021) Vol. 10, Iss. 1, pp. 42-42
Open Access | Times Cited: 183
A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier
Elizabeth M. Hart, Angela M. Mitchell, Anna Konovalova, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 43, pp. 21748-21757
Open Access | Times Cited: 161
Elizabeth M. Hart, Angela M. Mitchell, Anna Konovalova, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 43, pp. 21748-21757
Open Access | Times Cited: 161
Phage-Encoded Endolysins
Fatma Abdelrahman, Maheswaran Easwaran, Oluwasegun I. Daramola, et al.
Antibiotics (2021) Vol. 10, Iss. 2, pp. 124-124
Open Access | Times Cited: 156
Fatma Abdelrahman, Maheswaran Easwaran, Oluwasegun I. Daramola, et al.
Antibiotics (2021) Vol. 10, Iss. 2, pp. 124-124
Open Access | Times Cited: 156
Antibiotic Resistance: From the Bench to Patients
Márió Gajdács, Fernando Alberício
Antibiotics (2019) Vol. 8, Iss. 3, pp. 129-129
Open Access | Times Cited: 149
Márió Gajdács, Fernando Alberício
Antibiotics (2019) Vol. 8, Iss. 3, pp. 129-129
Open Access | Times Cited: 149
Multitarget Approaches against Multiresistant Superbugs
Declan A. Gray, Michaela Wenzel
ACS Infectious Diseases (2020) Vol. 6, Iss. 6, pp. 1346-1365
Open Access | Times Cited: 143
Declan A. Gray, Michaela Wenzel
ACS Infectious Diseases (2020) Vol. 6, Iss. 6, pp. 1346-1365
Open Access | Times Cited: 143
Antimicrobial Resistance in the Context of the Sustainable Development Goals: A Brief Review
Márió Gajdács, Edit Urbán, Anette Stájer, et al.
European Journal of Investigation in Health Psychology and Education (2021) Vol. 11, Iss. 1, pp. 71-82
Open Access | Times Cited: 127
Márió Gajdács, Edit Urbán, Anette Stájer, et al.
European Journal of Investigation in Health Psychology and Education (2021) Vol. 11, Iss. 1, pp. 71-82
Open Access | Times Cited: 127
Inorganic Nanoparticles and Composite Films for Antimicrobial Therapies
Vera Alexandra Spirescu, Cristina Chircov, Alexandru Mihai Grumezescu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4595-4595
Open Access | Times Cited: 116
Vera Alexandra Spirescu, Cristina Chircov, Alexandru Mihai Grumezescu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4595-4595
Open Access | Times Cited: 116
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
Ghazala Muteeb, Md Tabish Rehman, Moyad Shahwan, et al.
(2023)
Open Access | Times Cited: 85
Ghazala Muteeb, Md Tabish Rehman, Moyad Shahwan, et al.
(2023)
Open Access | Times Cited: 85
Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020
Neha Prasad, Ian B. Seiple, Ryan T. Cirz, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 5
Open Access | Times Cited: 71
Neha Prasad, Ian B. Seiple, Ryan T. Cirz, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 5
Open Access | Times Cited: 71
Nanosystems as Vehicles for the Delivery of Antimicrobial Peptides (AMPs)
Ángela Martín‐Serrano Ortiz, Rafael Gómez, Paula Ortega, et al.
Pharmaceutics (2019) Vol. 11, Iss. 9, pp. 448-448
Open Access | Times Cited: 119
Ángela Martín‐Serrano Ortiz, Rafael Gómez, Paula Ortega, et al.
Pharmaceutics (2019) Vol. 11, Iss. 9, pp. 448-448
Open Access | Times Cited: 119
Evidence of the Practice of Self-Medication with Antibiotics among the Lay Public in Low- and Middle-Income Countries: A Scoping Review
Adeel Aslam, Márió Gajdács, Che Suraya Zin, et al.
Antibiotics (2020) Vol. 9, Iss. 9, pp. 597-597
Open Access | Times Cited: 118
Adeel Aslam, Márió Gajdács, Che Suraya Zin, et al.
Antibiotics (2020) Vol. 9, Iss. 9, pp. 597-597
Open Access | Times Cited: 118
Comparative Epidemiology and Resistance Trends of Common Urinary Pathogens in a Tertiary-Care Hospital: A 10-Year Surveillance Study
Márió Gajdács, Marianna Ábrók, Andrea Lázár, et al.
Medicina (2019) Vol. 55, Iss. 7, pp. 356-356
Open Access | Times Cited: 99
Márió Gajdács, Marianna Ábrók, Andrea Lázár, et al.
Medicina (2019) Vol. 55, Iss. 7, pp. 356-356
Open Access | Times Cited: 99
Utility of Photodynamic Therapy in Dentistry: Current Concepts
Anette Stájer, Szilvia Kajári, Márió Gajdács, et al.
Dentistry Journal (2020) Vol. 8, Iss. 2, pp. 43-43
Open Access | Times Cited: 93
Anette Stájer, Szilvia Kajári, Márió Gajdács, et al.
Dentistry Journal (2020) Vol. 8, Iss. 2, pp. 43-43
Open Access | Times Cited: 93
Antibacterial Prodrugs to Overcome Bacterial Resistance
Buthaina Jubeh, Zeinab Breijyeh, Rafik Karaman
Molecules (2020) Vol. 25, Iss. 7, pp. 1543-1543
Open Access | Times Cited: 86
Buthaina Jubeh, Zeinab Breijyeh, Rafik Karaman
Molecules (2020) Vol. 25, Iss. 7, pp. 1543-1543
Open Access | Times Cited: 86
Increasing relevance of Gram-positive cocci in urinary tract infections: a 10-year analysis of their prevalence and resistance trends
Márió Gajdács, Marianna Ábrók, Andrea Lázár, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 86
Márió Gajdács, Marianna Ábrók, Andrea Lázár, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 86
Correlation Between Biofilm-Formation and the Antibiotic Resistant Phenotype in Staphylococcus aureus Isolates: A Laboratory-Based Study in Hungary and a Review of the Literature
Seyyed Askhan Senobar Tahaei, Anette Stájer, Ibrahim Barrak, et al.
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 1155-1168
Open Access | Times Cited: 83
Seyyed Askhan Senobar Tahaei, Anette Stájer, Ibrahim Barrak, et al.
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 1155-1168
Open Access | Times Cited: 83
Characterization of Resistance in Gram-Negative Urinary Isolates Using Existing and Novel Indicators of Clinical Relevance: A 10-Year Data Analysis
Márió Gajdács, Zoltán Bátori, Marianna Ábrók, et al.
Life (2020) Vol. 10, Iss. 2, pp. 16-16
Open Access | Times Cited: 81
Márió Gajdács, Zoltán Bátori, Marianna Ábrók, et al.
Life (2020) Vol. 10, Iss. 2, pp. 16-16
Open Access | Times Cited: 81
Knowledge, Attitude and Practice of Community Pharmacists Regarding Antibiotic Use and Infectious Diseases: A Cross-Sectional Survey in Hungary (KAPPhA-HU)
Márió Gajdács, Edit Paulik, Andrea Szabó
Antibiotics (2020) Vol. 9, Iss. 2, pp. 41-41
Open Access | Times Cited: 80
Márió Gajdács, Edit Paulik, Andrea Szabó
Antibiotics (2020) Vol. 9, Iss. 2, pp. 41-41
Open Access | Times Cited: 80
Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs
Catherine Vilchèze
Applied Sciences (2020) Vol. 10, Iss. 7, pp. 2278-2278
Open Access | Times Cited: 71
Catherine Vilchèze
Applied Sciences (2020) Vol. 10, Iss. 7, pp. 2278-2278
Open Access | Times Cited: 71
In vitro blood brain barrier models: An overview
Ekta Jagtiani, Mihika Yeolekar, Shivraj Naik, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 13-30
Closed Access | Times Cited: 53
Ekta Jagtiani, Mihika Yeolekar, Shivraj Naik, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 13-30
Closed Access | Times Cited: 53